Phase II study of spartalizumab (PDR001) vs chemotherapy (CT) in patients with recurrent/metastatic nasopharyngeal cancer (NPC)
Darren Wan-Teck Lim,Hung-Ming Wang,Shau-Hsuan Li,Roger Ngan,Arunee Dechaphunkul,Li Zhang,Chia Jui Yen,Po Chung Chan,Somvilai Chakrabandhu,Brigette Ma,Suebpong Tanasanvimon,Victor Lee,Pei-Jen Lou,Zujun Li,Alexander Spira,Ammar Sukari,Joel Guigay, Steven McCune,Yongjian Sun,Sebastian Szpakowski,Yao Yao,Xueqiang Fan,Luigi Manenti,Caroline Even CANCER RESEARCH（2019）
AI 理解论文
溯源树
样例
